Type of medicine: Herbal and homoeopathic medicines
|
Therapeutic area: Mental Disorders [F03]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: (HERB) Dry extract from Ginkgo biloba leaves (35-67 :1), extraction solvent: acetone 60% (w/w). The extract is adjusted to 22.0 - 27.0 % ginkgo flavonoids calculated as ginkgo flavone glycosides and 5.0 - 7.0 % terpene lactones consisting of 2.8 - 3.4 % ginkgolides A, B, C and 2.6 - 3.2 % bilobalide and contains less than 5 ppm ginkgolic acids. |
ATC code: N06DX02 / N06DP01 |
Document link:
|
Document date: 2011-10-19
|
Study number: 523001.01.065 |
EudraCT number:
|
Scope of study: CLINICAL |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
-
|